ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
coads
|
26 |
7.0K |
1 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
26
|
7.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
coads
|
26 |
7.0K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
26
|
7.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
coads
|
26 |
7.0K |
0 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
26
|
7.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
coads
|
26 |
7.0K |
6 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
26
|
7.0K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
coads
|
1.1K |
296K |
16 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.1K
|
296K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
coads
|
26 |
7.0K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
26
|
7.0K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
coads
|
1.1K |
296K |
5 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
1.1K
|
296K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
coads
|
26 |
7.0K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
26
|
7.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Annual Report to shareholders
|
|
coads
|
17 |
5.1K |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
17
|
5.1K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
coads
|
496 |
153K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
496
|
153K
|
2
|
|
ASX - By Stock
|
TON |
Re:
Ann: Corporate Governance Statement
|
|
coads
|
31 |
10K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
31
|
10K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
coads
|
100 |
25K |
5 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
100
|
25K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
coads
|
100 |
25K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
100
|
25K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
coads
|
496 |
153K |
5 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
496
|
153K
|
5
|
|
ASX - By Stock
|
TON |
Re:
Ann: Corporate Governance Statement
|
|
coads
|
31 |
10K |
0 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
31
|
10K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
coads
|
77 |
18K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
18K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Where to get OrthoACI in Perth?
|
|
coads
|
3 |
715 |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
3
|
715
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
coads
|
20 |
7.1K |
8 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
20
|
7.1K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
coads
|
77 |
18K |
9 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
coads
|
24 |
7.3K |
6 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
24
|
7.3K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
coads
|
1.1K |
296K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.1K
|
296K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
coads
|
24 |
7.3K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
24
|
7.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
J&J Acqusition
|
|
coads
|
14 |
4.0K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
14
|
4.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
J&J Acqusition
|
|
coads
|
14 |
4.0K |
0 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
14
|
4.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
J&J Acqusition
|
|
coads
|
14 |
4.0K |
2 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
14
|
4.0K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Cap Raise - Nasdaq listing
|
|
coads
|
27 |
7.3K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
27
|
7.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Cap Raise - Nasdaq listing
|
|
coads
|
27 |
7.3K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
27
|
7.3K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
coads
|
66 |
17K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
66
|
17K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
coads
|
66 |
17K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
66
|
17K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
coads
|
55 |
14K |
15 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
14K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
coads
|
55 |
14K |
12 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
14K
|
12
|
|
ASX - By Stock
|
OCC |
Re:
Stem Cell Therapy advancements
|
|
coads
|
455 |
146K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
455
|
146K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
coads
|
13 |
3.1K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13
|
3.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
coads
|
13 |
3.1K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13
|
3.1K
|
0
|
|
ASX - By Stock
|
TON |
Re:
Ann: Corporate Governance Statement
|
|
coads
|
31 |
10K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
31
|
10K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
coads
|
13 |
3.1K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13
|
3.1K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
coads
|
13 |
3.1K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13
|
3.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
coads
|
13 |
3.1K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13
|
3.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
coads
|
13 |
3.1K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
13
|
3.1K
|
0
|
|
ASX - By Stock
|
TON |
Re:
Ann: Corporate Governance Statement
|
|
coads
|
31 |
10K |
1 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
31
|
10K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
coads
|
33 |
8.3K |
11 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
33
|
8.3K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Medtronic Latest
|
|
coads
|
5 |
2.5K |
0 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
5
|
2.5K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
coads
|
33 |
8.3K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
33
|
8.3K
|
6
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Part 1 Remplir US Market Authorisation Successfully Complete
|
|
coads
|
35 |
9.7K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
35
|
9.7K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
coads
|
196 |
36K |
5 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
196
|
36K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
What’s next???
|
|
coads
|
17 |
7.2K |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
17
|
7.2K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
coads
|
196 |
36K |
5 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
196
|
36K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
coads
|
196 |
36K |
13 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
196
|
36K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
coads
|
196 |
36K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
196
|
36K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
coads
|
100 |
25K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
100
|
25K
|
6
|
|